We research mouse models to advance the care of skeletal diseases.
The Greenblatt lab at Weill Cornell uses mouse genetics to identify new drug targets either for the treatment of a wide range of skeletal diseases, including osteoporosis, tumor-mediated bone destruction or to serve as adjuncts to enhance the outcome of orthopedic procedures. Additionally, we use a combination of flow cytometry, lineage tracking and single cell RNA sequencing to identify new populations of skeletal stem cells and progenitors.
We are currently looking for new postdocs to join our team. Interested candidates should send a CV to email@example.com.